Real-world evidence for nucleoside/nucleotide analogues in a 5-year multicentre study of antiviral-naive chronic hepatitis B patients in China: 52-week results.,Antiviral Therapy

当前位置： X-MOL 学术 › Antivir. Ther. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Real-world evidence for nucleoside/nucleotide analogues in a 5-year multicentre study of antiviral-naive chronic hepatitis B patients in China: 52-week results.
Antiviral Therapy ( IF 1.2 ) Pub Date : 2017-11-9 , DOI: 10.3851/imp3205
Jidong Jia ₁ , Hong Tang ₂ , Qin Ning ₃ , Jiaji Jiang ₄ , Xiaoguang Dou ₅ , Mingxiang Zhang ₆ , Shuqin Zhang ₇ , Jia Shang ₈ , Wei Lu ₉ , Yinong Ye ₁₀ , Xin Wang ₁₁ , Mingshu Li ₁₂ , Jie Liu ₁₂ , Qingyan Bo ₁₂ , Wenzhong Tan ₁₂ ,

Affiliation

Beijing Friendship Hospital, Capital Medical University, Beijing, China.
West China Hospital, Sichuan University, Chengdu, China.
Affiliated Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China.
The First Affiliated Hospital of Fujian Medical University, Fuzhou, China.
Shengjing Hospital of China Medical University, Shenyang, China.
The Sixth People's Hospital of Shenyang, Shenyang, China.
Hepatology Hospital of Jilin Province, Changchun, China.
Henan Provincial People's Hospital, Zhengzhou, China.
The Second People's Hospital of Tianjin, Tianjin, China.
The First People's Hospital of Foshan, Foshan, China.
GCP ClinPlus Co., Ltd, Beijing, China.
Bristol-Myers Squibb, Shanghai, China.

In China, the clinical management of chronic hepatitis B (CHB) is complicated by the use of variousnucleoside/nucleotide analogue (NUC) regimens in treatment-naive patients, including NUCs with low genetic barriers to resistance, with/without add-on therapy and de novo NUC combinations. This longitudinal observational study therefore investigated the real-world clinical management and efficacy of NUC therapy in treatment-naive CHB patients in China.

更新日期：2020-08-21

点击分享查看原文

点击收藏

公开下载

阅读更多本刊最新论文本刊介绍/投稿指南

全部期刊列表>>